Literature DB >> 17323724

In vitro evaluation of head and neck radiation shields used to reduce exit dose.

Bahar Dirican1, Julide Ozen, Murat Beyzadeoglu, Kaan Oysul, Serdar Surenkok, Cumhur Sipahi.   

Abstract

PURPOSE: To determine the optimal thickness of protective oral radiation shields composed of an acrylic resin stent and a lead shield, which are used in head and neck radiotherapy to minimize undesired normal tissue radiomorbidity.
MATERIALS AND METHODS: Intraoral acrylic resin stents and lead shields of different thicknesses were inserted into a specially designed human mandible phantom with thermoluminescent lithium fluoride dosimeter chips (TLD-100) placed on the buccal and lingual sites and exposed to irradiation of different energies. Fifty-cGy irradiation was performed and TLD-100 dose measurements were obtained for each irradiation type, acrylic resin stent thickness, and lead shield thickness.
RESULTS: Acrylic resin stents with a 2-mm lead shield reduced 20% and 15% of the normal tissue dose for Co-60 and 6 MV X photon radiations, respectively, whereas the stents with a 4-mm lead shield achieved a higher reduction of the normal tissue dose (30% and 23% for Co-60 and 6 MV X photons, respectively).
CONCLUSION: In protective oral radiation shields, acrylic resin stent thickness has little effect on the reduction of normal tissue dose, but lead shield thickness significantly effects the reduction of normal tissue dose.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17323724

Source DB:  PubMed          Journal:  Int J Prosthodont        ISSN: 0893-2174            Impact factor:   1.681


  2 in total

1.  Influence of lead apron shielding on absorbed doses from panoramic radiography.

Authors:  D Rottke; L Grossekettler; K Sawada; P Poxleitner; D Schulze
Journal:  Dentomaxillofac Radiol       Date:  2013-10-30       Impact factor: 2.419

2.  Clinical Risk Factors Influencing Dental Developmental Disturbances in Childhood Cancer Survivors.

Authors:  Chung-Min Kang; Seung Min Hahn; Hyo Sun Kim; Chuhl Joo Lyu; Jae-Ho Lee; Jinae Lee; Jung Woo Han
Journal:  Cancer Res Treat       Date:  2017-10-10       Impact factor: 4.679

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.